6-K 1 a3372y.htm RESULT OF AGM a3372y
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the month of May 2023
 
Commission File Number 001-15170
 
 
GSK plc
(Translation of registrant's name into English)
 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive office)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
 
 
 
 
 
GSK plc
 
Results of 23rd Annual General Meeting
 
GSK plc ('GSK') held a hybrid Annual General Meeting ('AGM') at 2.30pm on Wednesday 3 May 2023 at the Sofitel Hotel in Terminal 5 Heathrow. Shareholders were able to join the meeting in person or virtually via the Lumi AGM website.
 
All valid proxy votes (whether submitted electronically or in hard copy form) were included in the poll taken at the meeting.
 
The table below shows the results of the poll on all 23 resolutions. The full text of the resolutions is contained in the Notice of AGM published on 27 March 2023, which is available on GSK's website at www.gsk.com.
 
Resolution
Total votes for(1)(2)
%
Total votes against(2)
%
Total votes cast
Votes withheld(3)
1
Receive and adopt the 2022 Annual Report
2,838,286,554
99.05
27,282,840
0.95
2,865,569,394
11,463,434
2
Approve the Annual report on remuneration 
2,493,636,361
88.84
313,256,226
11.16
2,806,892,587
70,129,301
3
Election of Julie Brown
2,857,379,637
99.59
11,814,146
0.41
2,869,193,783
7,831,272
4
Election of Dr Vishal Sikka
2,860,647,976
99.69
8,837,033
0.31
2,869,485,009
7,534,298
5
Election of Elizabeth McKee Anderson
2,744,478,188
95.64
125,073,699
4.36
2,869,551,887
7,475,279
6
Re-election of Sir Jonathan Symonds
2,774,824,580
96.72
94,170,389
3.28
2,868,994,969
8,020,637
7
Re-election of Dame Emma Walmsley
2,862,165,104
99.74
7,358,771
0.26
2,869,523,875
7,508,911
8
Re-election of Charles Bancroft
2,786,237,098
97.24
79,167,334
2.76
2,865,404,432
11,602,033
9
Re-election of Dr Hal Barron
2,845,192,710
99.17
23,938,850
0.83
2,869,131,560
7,896,993
10
Re-election of Dr Anne Beal
2,788,179,755
97.17
81,326,824
2.83
2,869,506,579
7,517,274
11
Re-election of Dr Harry C Dietz
2,863,558,514
99.83
4,932,171
0.17
2,868,490,685
8,534,053
12
Re-election of Dr Jesse Goodman
2,863,346,622
99.79
6,079,498
0.21
2,869,426,120
7,596,197
13
Re-election of Urs Rohner
2,627,550,485
91.58
241,613,171
8.42
2,869,163,656
7,856,370
14
Re-appointment of the auditor
2,846,403,783
99.86
4,095,644
0.14
2,850,499,427
26,524,596
15
Remuneration of the auditor
2,865,552,679
99.83
4,889,379
0.17
2,870,442,058
6,575,928
16
Approve amendments to the Directors' Remuneration Policy
2,837,886,999
99.01
28,431,513
0.99
2,866,318,512
10,705,019
17
Authority for the company to make donations to political organisations and incur political expenditure
2,778,351,786
98.69
36,846,645
1.31
2,815,198,431
61,881,372
18
Authority to allot shares
2,749,592,663
95.85
118,984,091
4.15
2,868,576,754
8,438,938
19
Disapplication of pre-emption rights - general power(4)
2,774,457,577
96.79
91,974,467
3.21
2,866,432,044
10,561,299
20
Disapplication of pre-emption rights - in connection with an acquisition or specified capital investment(4)
2,747,347,831
95.84
119,258,296
4.16
2,866,606,127
10,393,035
21
Authority for the company to purchase its own shares(4)
2,821,937,695
98.36
47,051,419
1.64
2,868,989,114
8,025,806
22
Exemption from statement of senior statutory auditor's name
2,856,668,700
99.67
9,373,459
0.33
2,866,042,159
10,967,927
23
Authority for reduced notice of a general meeting other than an AGM(4)
2,698,567,258
94.08
169,932,106
5.92
2,868,499,364
8,505,572
 
 
Notes:
 
(1)      The "for" votes include those giving the Chair discretion.
(2)      Votes "for" and "against" are expressed as a percentage of the total votes cast.
(3)      A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "for" or "against" a resolution.
(4)      Indicates Special Resolutions requiring a 75% majority of votes cast.
 
 
The following table provides further information on participation in the AGM:
 
 
 
GSK's 23rd AGM
(Hybrid meeting)
(2023)
 
GSK's 22nd AGM
(Hybrid meeting)
(2022)
Issued share capital (excluding Treasury Shares)
4,094,980,743
5,083,974,547
Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)
70.26%
70.25%
Total shareholder population
63,362
89,764
Total number of proxies lodged
3,162
5,343
Number of shareholders in attendance
72 in person
49 participated virtually
93 in person
68 participated virtually
% of shareholders who lodged proxies
4.99%
5.95%
 
The above poll results will shortly be available on the company's website at www.gsk.com.
 
In accordance with Listing Rule 9.6.2 of the Financial Conduct Authority's (FCA) Listing Rules, a copy of the resolutions, other than those concerning ordinary business, will be submitted to the FCA and will in due course be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
 
 
V A Whyte
Company Secretary
3 May 2023
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
GSK plc
 
(Registrant)
 
 
Date: May 03, 2023
 
 
 
 
By:/s/ VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GSK plc